Voyager Therapeutics, Inc. - Common Stock (VYGR)
3.4100
+0.0400 (1.19%)
NASDAQ · Last Trade: Apr 2nd, 5:02 PM EDT
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Dave, Inc. (NASDAQ: DAVE), Red Cat Holdings, Inc. (NASDAQ: RCAT), Perpetua Resources Corp. (NASDAQ:PPTA), and Voyager Therapeutics, Inc. (NASDAQ:VYGR). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · March 20, 2025

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Voyager Therapeutics, Inc. (“Voyager” or the “Company”) (NASDAQ:VYGR) on behalf of Voyager stockholders. Our investigation concerns whether Voyager has violated the federal securities laws and/or engaged in other unlawful business practices.
By Bragar Eagel & Squire · Via GlobeNewswire · February 24, 2025

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Voyager Therapeutics, Inc. (“Voyager” or “the Company”) (NASDAQ: VYGR) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · February 20, 2025
Voyager Therapeutics Inc. (NASDAQ: VYGR) Near the Top of Equities by Percentage Gain on 1/3
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is one of today’s top gainers. The company’s shares have moved 1.72% on the day to $6.52.
Via Investor Brand Network · January 3, 2024
Voyager Therapeutics Inc. (NASDAQ: VYGR) Near the Top of Equities by Percentage Gain on 1/2
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is one of today’s top gainers. The company’s shares have moved 1.72% on the day to $6.52.
Via Investor Brand Network · January 2, 2024

Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took
Via MarketBeat · January 8, 2024
Intranasal Ketamine Garnering A lot of Attention as an Effective Treatment For Depression
Palm Beach, FL –November 23, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic is expected to have a significant positive impact on the growth of the global antidepressant market. The pandemic is predicted to have a long and short term impact on the individual’s mental illness, given the hurdles faced during the crisis, such […]
Via FinancialNewsMedia · November 23, 2021
San Diego, CA -- (SBWIRE) -- 05/05/2021 -- Certain directors of Voyager Therapeutics, Inc. are under investigation over possible breaches of fiduciary duties.
Via SBWire · May 5, 2021